Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIEL4: Rubraca vs Chemotherapy in Relapsed Ovarian Cancer
NCT02855944Phase 3Completed
- Sponsor
- pharma&
- Start
- Mar 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of rucaparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by pharma&. Started Mar 2017; status: completed.
02
Drugs
rucaparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02855944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855944.